This NPM-ALK fusion protein, which is highly tyrosine phosphorylated and recruits more than 40 proteins, has been reported to promote ALCL progression by triggering activation of transduction pathways primarily involved in proliferative and antiapoptotic responses3, 4. The gene discussed is NPM1; the disease is anaplastic large cell lymphoma.